volume 1, issue 1, P100014 2020
DOI: 10.1016/j.xpro.2020.100014
View full text
|
Sign up to set email alerts
|
Share

Abstract: Summary De novo identification of chromatin interactors can reveal unexpected pathways relevant to physiology and human disease. Inspired by the DNA mediated chromatin pull-down (Dm-ChP) technology (also known as iPOND [isolation of proteins on nascent DNA]) for the proteomic characterization of nascent DNA, we have recently reported a new experimental protocol that allows for the identification of proteins on total DNA (iPOTD) for bulk chromatome profiling and de novo …

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
4
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals